Publication

Byline

Location

US Patent Issued to ROUSSELOT on May 26 for "Hydrolyzed collagen for use in reducing blood glucose" (Belgian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,339, issued on May 26, was assigned to ROUSSELOT B.V. (Ghent, Belgium). "Hydrolyzed collagen for use in reducing blood glucose" was invented... और पढ़ें


US Patent Issued to ONYX PHARMACEUTICALS, Janssen Biotech on May 26 for "Methods of treating multiple myeloma" (California Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,340, issued on May 26, was assigned to ONYX PHARMACEUTICALS INC. (Thousand Oaks, Calif.) and Janssen Biotech Inc. (Horsham, Pa.). "Methods o... और पढ़ें


US Patent Issued to VLP Therapeutics on May 26 for "Galectin-targeting immunotherapy" (Maryland Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,341, issued on May 26, was assigned to VLP Therapeutics Inc. (Wilmington, Del.). "Galectin-targeting immunotherapy" was invented by Wataru A... और पढ़ें


US Patent Issued to KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on May 26 for "TARS derived from Akkermansia muciniphila or fragment thereof, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,342, issued on May 26, was assigned to KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (Daejeon, South Korea) and SEOUL NATIONAL UNI... और पढ़ें


US Patent Issued to Penland Foundation on May 26 for "Treatment of vestibular vertigo using botulinum toxins" (Texas Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,343, issued on May 26, was assigned to Penland Foundation (Beaumont, Texas). "Treatment of vestibular vertigo using botulinum toxins" was in... और पढ़ें


US Patent Issued to Regeneron Pharmaceuticals on May 26 for "Preferentially expressed antigen in melanoma (PRAME) T cell receptors and methods of use thereof" (Connecticut Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,344, issued on May 26, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.). "Preferentially expressed antigen in melanoma (PRAM... और पढ़ें


US Patent Issued to The Regents of the University of California on May 26 for "Methods of treating glioblastomas" (California Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,345, issued on May 26, was assigned to The Regents of the University of California (Oakland, Calif.). "Methods of treating glioblastomas" wa... और पढ़ें


US Patent Issued to KOLON LIFE SCIENCE on May 26 for "Composition for treating pain" (South Korean Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,346, issued on May 26, was assigned to KOLON LIFE SCIENCE INC. (Seoul, South Korea). "Composition for treating pain" was invented by Sujeong... और पढ़ें


US Patent Issued on May 26 for "Recombinant interferon with changed spatial configuration" (Chinese Inventor)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,347, issued on May 26. "Recombinant interferon with changed spatial configuration" was invented by Guangwen Wei (Chengdu, China). According... और पढ़ें


US Patent Issued to Avalanche Australia on May 26 for "Treatment of ocular neovascularization using anti-vegf proteins" (Australian, American Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,348, issued on May 26, was assigned to Avalanche Australia Pty Ltd (Southbank, Australia). "Treatment of ocular neovascularization using ant... और पढ़ें